Clinical Trials Directory

Trials / Completed

CompletedNCT05688917

Green Coffee Effect on Metabolic Syndrome

Effect of Green Coffee Supplementation on Inflammatory Biomarkers in Obese Patients With Metabolic Syndrome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
160 (actual)
Sponsor
Tanta University · Academic / Other
Sex
All
Age
20 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The present study aimed to investigate the effect of green coffee bean extract (GCBE) on the inflammatory biomarkers in obese patients with a metabolic syndrome via analyzing some inflammatory biomarkers as resistin, TNF-α, total sialic acid, homocysteine, high sensitivity C-reactive protein (hs-CRP) and anti-inflammatory cytokine, adiponectin

Detailed description

160 obese patients supplemented with either GCBE capsules (800 mg) daily or placebo for 6 months and advised to take a balanced diet. Blood samples were collected at baseline and after three months of supplementation

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTGreen coffee been extractsupportive treatment
OTHERPlaceboPlacebo capsule

Timeline

Start date
2020-09-03
Primary completion
2022-09-01
Completion
2022-09-30
First posted
2023-01-18
Last updated
2023-05-26

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05688917. Inclusion in this directory is not an endorsement.